Quick Answer
Amneal Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $0.22 per share for the year ending 2025.
- Amneal Pharmaceuticals, Inc. showed an increase of +157.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Amneal Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $0.05 per share | Q1 2019: $0.37 (loss) per share | Q2 2019: $0.13 (loss) per share | Q3 2019: $2.03 (loss) per share | Q1 2020: $0.78 per share | Q2 2020: $0.08 (loss) per share | Q3 2020: $0.06 (loss) per share | Q1 2021: $0.04 per share | Q2 2021: $0.10 per share | Q3 2021: $0.03 (loss) per share | Q1 2022: $0.01 (loss) per share | Q2 2022: $0.80 (loss) per share | Q3 2022: $0.02 (loss) per share | Q1 2023: $0.05 (loss) per share | Q2 2023: $0.08 per share | Q3 2023: $0.06 per share | Q1 2024: $0.30 (loss) per share | Q2 2024: $0.02 per share | Q3 2024: $0.00 per share | Q1 2025: $0.04 per share | Q2 2025: $0.07 per share | Q3 2025: $0.01 per share.
- Over the full 8 years of available data (2018 to 2025), Amneal Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 237.5%.
- Historical annual values: Fiscal year 2025: $0.22 per share | Fiscal year 2024: $0.38 (loss) per share | Fiscal year 2023: $0.48 (loss) per share | Fiscal year 2022: $0.86 (loss) per share | Fiscal year 2021: $0.07 per share | Fiscal year 2020: $0.61 per share | Fiscal year 2019: $2.74 (loss) per share | Fiscal year 2018: $0.16 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: